Moxifloxacin 400 mg Tablet

• Moxifloxacin has potent activity against Mycobacterium tuberculosis when given with anti-tuberculosis chemotherapy
• Much more effective than beta lactamins and macrolildes for the treatment of excerbated COPD
• Significantly reduces time to recovery from COPD in patients with moderate to severe disease by approximately 20% (>1day) compared with other antimicrobials
• FDA approved bactericidal effective against Mycobacterium leprae thus beneficial in treatment of skin infection

Dosage:

• Pneumonia 400 mg : 7-14 days
• Chronic Bronchitis 400 mg : 5 days
• Skin & skin structure infections 400 mg:7-21 days